PowderMed spins off of Chiron; raises £20mm
PowderMed Ltd., a newly formed company focused on developing therapeutic DNA vaccines, has spun off from Chiron Vaccines and raised £20mm ($35.2mm).
- Drug Delivery
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com